Literature DB >> 18165943

Demonstrating safety through in-hospital mortality analysis following elective abdominal aortic aneurysm repair in England.

P J E Holt1, J D Poloniecki, I M Loftus, M M Thompson.   

Abstract

BACKGROUND: The aims were to assess the evidence that individual hospitals had mortality rates in excess of the national average after abdominal aortic aneurysm (AAA) repair and to develop an effective method for monitoring mortality using local data.
METHODS: Hospital Episode Statistics identified patients undergoing elective infrarenal AAA repair. A technique was developed that compared individual hospital mortality rates with the mortality rate in the remainder of England. The strength of evidence that the death rate was less than elsewhere, and less than twice elsewhere, was quantified using a test of statistical significance. A moving average chart technique was devised using local data for mortality monitoring and comparison to the national average.
RESULTS: For 30 hospitals, the mortality rate was significantly greater than elsewhere, and in three hospitals it was demonstrably greater than twice that in the remainder of England. The moving average chart appeared to provide a useful technique for local mortality monitoring.
CONCLUSION: Different mortality rates exist for AAA repair within England. Mortality can be monitored locally and compared with the national average. Copyright (c) 2007 British Journal of Surgery Society Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18165943     DOI: 10.1002/bjs.5990

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  2 in total

1.  How to improve surgical outcomes.

Authors:  Peter J E Holt; Jan D Poloniecki; Matt M Thompson
Journal:  BMJ       Date:  2008-04-21

2.  Outcomes of aortic aneurysm surgery in England: a nationwide cohort study using hospital admissions data from 2002 to 2015.

Authors:  Ahmed Aber; Thaison Tong; Jim Chilcott; Ravi Maheswaran; Steven M Thomas; Shah Nawaz; Jonathan Michaels
Journal:  BMC Health Serv Res       Date:  2019-12-23       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.